HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 201 filers reported holding HERBALIFE LTD in Q3 2023. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $92,988,000 | -37.1% | 3,062,839 | -15.2% | 4.74% | -18.4% |
| Q4 2021 | $147,751,000 | -6.9% | 3,609,850 | -3.6% | 5.80% | -7.5% |
| Q3 2021 | $158,726,000 | +1.5% | 3,745,293 | +26.3% | 6.28% | +1.9% |
| Q2 2021 | $156,348,000 | +20.7% | 2,965,075 | +1.5% | 6.16% | +7.5% |
| Q1 2021 | $129,531,000 | -26.9% | 2,919,990 | -20.8% | 5.73% | -20.3% |
| Q4 2020 | $177,160,000 | -6.8% | 3,686,985 | -9.5% | 7.19% | -16.8% |
| Q3 2020 | $190,140,000 | -42.1% | 4,075,874 | -44.2% | 8.64% | -49.4% |
| Q2 2020 | $328,637,000 | -10.5% | 7,306,300 | -42.0% | 17.10% | -46.3% |
| Q1 2020 | $367,246,000 | -26.1% | 12,594,180 | +20.8% | 31.82% | -21.3% |
| Q4 2019 | $497,172,000 | +11.2% | 10,429,442 | -11.7% | 40.45% | +4.1% |
| Q3 2019 | $446,953,000 | +7.3% | 11,805,408 | +21.2% | 38.87% | +8.9% |
| Q2 2019 | $416,398,000 | +29.5% | 9,738,033 | +60.5% | 35.69% | +46.5% |
| Q1 2019 | $321,481,000 | -12.7% | 6,066,830 | -2.9% | 24.36% | -12.5% |
| Q4 2018 | $368,180,000 | +6.8% | 6,245,630 | -1.2% | 27.85% | +9.0% |
| Q3 2018 | $344,780,000 | -15.5% | 6,320,447 | -16.8% | 25.55% | -17.6% |
| Q2 2018 | $408,132,000 | -3.3% | 7,597,400 | +75.5% | 31.00% | -13.4% |
| Q1 2018 | $421,870,000 | -17.2% | 4,328,200 | -42.5% | 35.80% | -10.9% |
| Q4 2017 | $509,306,000 | -4.0% | 7,520,766 | -3.8% | 40.18% | +9.8% |
| Q3 2017 | $530,306,000 | -1.6% | 7,818,160 | +3.5% | 36.60% | +12.3% |
| Q2 2017 | $538,898,000 | +19.6% | 7,555,000 | -2.5% | 32.59% | +7.3% |
| Q1 2017 | $450,608,000 | +22.4% | 7,750,400 | +1.3% | 30.39% | +13.3% |
| Q4 2016 | $368,161,000 | +52.0% | 7,647,712 | +95.7% | 26.81% | +19.2% |
| Q3 2016 | $242,214,000 | +93.9% | 3,907,300 | +83.0% | 22.49% | +52.4% |
| Q2 2016 | $124,946,000 | -25.3% | 2,134,728 | -21.4% | 14.76% | +0.8% |
| Q1 2016 | $167,209,000 | +167.2% | 2,716,199 | +132.8% | 14.63% | +79.0% |
| Q4 2015 | $62,572,000 | -1.6% | 1,166,953 | 0.0% | 8.18% | -14.0% |
| Q3 2015 | $63,599,000 | -1.1% | 1,166,953 | 0.0% | 9.50% | -35.1% |
| Q2 2015 | $64,287,000 | +28.8% | 1,166,953 | 0.0% | 14.65% | +17.7% |
| Q1 2015 | $49,899,000 | – | 1,166,953 | – | 12.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |